Ethical Dilemma for Ebola Drug Trials
November 11, 2014
(Nature) – With clinical trials of experimental Ebola treatments set to begin in December, public-health officials face a major ethical quandary: should some participants be placed in a control group that receives only standard symptomatic treatment, despite a mortality rate of around 70% for Ebola in West Africa? Two groups planning trials in Guinea and Liberia are diverging on this point, and key decisions for both are likely to come this week.